OBJECTIVE: To update recommendations for the treatment of @entity5144 with biological therapies, endorsed by the Portuguese Society of Rheumatology ( @entity29552 ). METHODS: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. At a national meeting the 16 recommendations included in this document were discussed and updated. The level of agreement among Portuguese Rheumatologists was assessed using an online survey. A draft of the full text of the recommendations was then circulated and suggestions were incorporated. A final version was again circulated before publication. RESULTS: A consensus was achieved regarding the initiation, assessment of response and switching biological therapies in @entity1 with @entity5144 ( @entity5144 ). Specific recommendations were developed for several disease domains: peripheral @entity625 , @entity66 , @entity4932 and dactylitis. CONCLUSION: These recommendations may be used for guidance in deciding which @entity1 with @entity5144 should be treated with biological therapies. They cover a rapidly evolving area of therapeutic intervention. As more evidence becomes available and more biological therapies are licensed, these recommendations will have to be updated.

PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN XXXX WITH PSORIATIC ARTHRITIS - 2015 UPDATE.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity625 :: ('MESH:D001168', 'Disease') :: ['arthritis'] @entity66 :: ('MESH:D004194', 'Disease') :: ['axial disease'] @entity29552 :: ('6697', 'Gene') :: ['SPR'] @entity5144 :: ('MESH:D015535', 'Disease') :: ['PsA', 'psoriatic arthritis'] @entity4932 :: ('MESH:D001171', 'Disease') :: ['enthesitis']
@entity1 :: (9606,Species) :: ['PATIENTS']
